Correlation Between Rapport Therapeutics, and Valmont Industries

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Rapport Therapeutics, and Valmont Industries at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rapport Therapeutics, and Valmont Industries into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rapport Therapeutics, Common and Valmont Industries, you can compare the effects of market volatilities on Rapport Therapeutics, and Valmont Industries and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rapport Therapeutics, with a short position of Valmont Industries. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rapport Therapeutics, and Valmont Industries.

Diversification Opportunities for Rapport Therapeutics, and Valmont Industries

0.23
  Correlation Coefficient

Modest diversification

The 3 months correlation between Rapport and Valmont is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Rapport Therapeutics, Common and Valmont Industries in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Valmont Industries and Rapport Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rapport Therapeutics, Common are associated (or correlated) with Valmont Industries. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Valmont Industries has no effect on the direction of Rapport Therapeutics, i.e., Rapport Therapeutics, and Valmont Industries go up and down completely randomly.

Pair Corralation between Rapport Therapeutics, and Valmont Industries

Given the investment horizon of 90 days Rapport Therapeutics, Common is expected to under-perform the Valmont Industries. In addition to that, Rapport Therapeutics, is 2.68 times more volatile than Valmont Industries. It trades about -0.18 of its total potential returns per unit of risk. Valmont Industries is currently generating about -0.35 per unit of volatility. If you would invest  33,665  in Valmont Industries on October 9, 2024 and sell it today you would lose (2,887) from holding Valmont Industries or give up 8.58% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Rapport Therapeutics, Common  vs.  Valmont Industries

 Performance 
       Timeline  
Rapport Therapeutics, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Rapport Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Rapport Therapeutics, is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.
Valmont Industries 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Valmont Industries are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite fairly abnormal primary indicators, Valmont Industries may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Rapport Therapeutics, and Valmont Industries Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Rapport Therapeutics, and Valmont Industries

The main advantage of trading using opposite Rapport Therapeutics, and Valmont Industries positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rapport Therapeutics, position performs unexpectedly, Valmont Industries can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Valmont Industries will offset losses from the drop in Valmont Industries' long position.
The idea behind Rapport Therapeutics, Common and Valmont Industries pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Global Correlations
Find global opportunities by holding instruments from different markets
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years